<SEC-DOCUMENT>0001654954-18-007335.txt : 20180705
<SEC-HEADER>0001654954-18-007335.hdr.sgml : 20180705
<ACCEPTANCE-DATETIME>20180703175137
ACCESSION NUMBER:		0001654954-18-007335
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180702
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180705
DATE AS OF CHANGE:		20180703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GT Biopharma, Inc.
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		18938730

	BUSINESS ADDRESS:	
		STREET 1:		1825 K STREET
		STREET 2:		SUITE 510
		CITY:			WASHINGTON, D.C.
		STATE:			DC
		ZIP:			33602
		BUSINESS PHONE:		(800) 304-9888

	MAIL ADDRESS:	
		STREET 1:		1825 K STREET
		STREET 2:		SUITE 510
		CITY:			WASHINGTON, D.C.
		STATE:			DC
		ZIP:			33602

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19940916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gtbp_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2018 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times\ New\ Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
UNITED STATES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Washington, D. C. 20549</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
FORM 8-K</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CURRENT REPORT</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Pursuant to Section 13 Or 15(d) of the</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Securities Exchange Act of 1934</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Date of
Report (Date of earliest event reported): July 2, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
GT Biopharma, Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Exact
name of Registrant as specified in its charter)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center">
<table cellpadding="0" cellspacing="0" style="text-align: center; width: 80%; font-family: Times\ New\ Roman; font-size: 13px; margin: 0px auto;">
<tr>
<td style="vertical-align: top; width: 33%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="text-decoration: underline">Delaware</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(State
or other Jurisdiction of Incorporation or
organization)</font></div>
</td>
<td style="vertical-align: top; width: 34%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">000-08092</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Commission
File Number)</font></div>
</td>
<td style="vertical-align: top; width: 34%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">94-1620407</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(IRS
Employer I.D. No.)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
1825 K Street</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Suite 510</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Washington, D.C. 20006</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Phone: (800) 304-9888</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Address,
including zip code, and telephone number, including area code,
of</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">registrant&#x2019;s
principal executive offices)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
N/A</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Former
name, former address and former fiscal year, if changed since last
report)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px"><font>&#x2610;</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px"><font>&#x2610;</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Soliciting material
pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l
4a- l 2)</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px"><font>&#x2610;</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Pre-commencement
communications pursuant to Rule l 4d-2(b) under the Exchange Act
(17 CFR 240. l 4d-2(b))</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px"><font>&#x2610;</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240. l 3e-4(c))</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (&#xA7;240.12b-2 of this chapter).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Emerging
growth company &#x2610;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. &#x2610;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: rgb(255, 255, 255);">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 1.01 Entry into a Material Definitive Agreement.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On July 2, 2018, GT Biopharma, Inc. (hereinafter the
&#x201C;Company&#x201D;) entered into indemnification agreements, in
substantially the form attached as Exhibit 10.1 to this Current
Report on Form 8-K (the &#x201C;Indemnification Agreement&#x201D;),
with each director serving on the Company&#x2019;s board of
directors (the &#x201C;Board&#x201D;) and each current executive
officer of the Company. The Indemnification Agreement is intended
to be entered into by the Company with its directors and executive
officers on or after July 2, 2018.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Under the Indemnification Agreement, the Company agrees to
indemnify each director and executive officer against any and all
expenses to the fullest extent permitted by the laws of the State
of Delaware, if the director/executive officer was, is, becomes or
is threatened to be made a party to or witness or other participant
in a claim or proceeding by reason of or arising in part out of the
director&#x2019;s/executive officer&#x2019;s service as a director,
officer, employee or other agent of the Company or any of its
subsidiaries. The Indemnification Agreement also provides for,
among other things, the advancement of expenses reasonably incurred
by a director/executive officer prior to final disposition of any
claim or proceeding that relates to the Company indemnification
obligations, subject to reimbursement in the event such
director/executive officer is ultimately determined not to be
entitled to indemnification under the terms of the Indemnification
Agreement and applicable Delaware law, and the maintenance by the
Company of director and officers&#x2019; liability insurance
covering the director/executive officer.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
The foregoing summary of the Indemnification Agreement is qualified
in its entirety by reference to, and should be read in conjunction
with, the complete text of the form of the Indemnification
Agreement, which is filed as Exhibit 10.1 to this Current Report on
Form 8-K and incorporated by reference into this Item
1.01.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
ITEM 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On July 2, 2018, each of Shawn Cross and Federica O&#x2019;Brien
resigned from the Board. Mr. Cross also resigned from his position
as Chief Executive Officer of the Company. These resignations were
effective as of July 2, 2018 and did not involve any disagreement
with the Company.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">
On July 3, 2018, the Board</font> appointed Dr. Raymond Urbanski
<font style="color: #000000; background-color: #FFFFFF">as the
Chief Executive Officer of the Company and the Chairman of the
Board and Dr. John N. Bonfiglio as a member of the
Board.&#xA0;&#xA0;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Dr. Urbanski, age 58, has been the Company&#x2019;s President since
May 2018, and has been the Company&#x2019;s Chief Medical Officer
since September 2017. Before joining the Company, he was the Chief
Medical Officer for MannKind Corporation (NASDAQ:MNKD) from August
2015 to September 2017. He was the Chief Medical Officer for Mylan
Inc. (NASDAQ:MYL) from August 2012 to September 2014. Dr. Urbanski
spent eight years with Pfizer Inc. (NYSE:PFE), or Pfizer, and held
several positions with Pfizer, including Vice President and Chief
Medical Officer of the Established Products Business Unit, Senior
Medical Director of Oncology Clinical R&amp;D, Senior Medical
Director of Breast Cancer Products and Medical Director of
Diversified Products. He brings extensive experience in developing
and overseeing clinical studies, including Phase 3b and Phase 4
studies (including line extensions) for sunitinib (Sutent),
exemestane (Aromasin), irinotecan (Camptosar), epirubicin
(Ellence), axitinib, IGF1R inhibitor, and tremilimumab. In addition
to his role with Pfizer, Dr. Urbanski has also served as Chief
Medical Officer of Metabolex Inc. from October 2011 to June 2012,
and senior director of U.S. Medical Affairs for Aventis (NYSE:SNY).
Dr. Ubanski received his Ph.D, and M.D. from the University of
Medicine and Dentistry of New Jersey &#x2013; New Jersey Medical
School.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Before joining the Company, Dr. Bonfiglio, was a consultant to
TapImmune Corporation (NASDAQ:TPIV) from February 2015 to July
2016, and later served as TapImmune Corporation&#x2019;s President
and Chief Operating Officer from July 2016 to April 2017. He was
the President and Chief Executive Officer of Oragenics
(NYSEAMERICAN:OGEN) from May 2011 to November 2014. He brings
extensive business management and strategic growth experience, with
a focus on the biopharmaceutical drug industry. Dr. Bonfiglio
previously served on the boards of directors of TapImmune
Corporation and Microlin Therapeutics. Dr. Bonfiglio received his
Ph.D. from the University of California at San Diego and his M.B.A.
from Pepperdine University.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Dr. Urbanski&#x2019;s compensation is not currently expected to
change in connection with this appointment. As previously
disclosed, Dr. Urbanksi is currently under a three-year employment
agreement pursuant to which he is paid an annual salary of $400,000
and he received a restricted stock award of 1,528,898 common shares
that vests over two years. Dr. Urbanksi will not receive any
additional compensation in connection with his position as a member
of the Board.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Dr. Bonfiglio will be paid an annual stipend of $42,500 for
director compensation and an additional $15,000 for Chairing a
Committee and $5,000 as a member of a
Committee.&#xA0;</font><font style="color: #000000; background-color: #FFFFFF">He will
also</font><font style="color: #000000">&#xA0;be granted 150,000
stock options that vest monthly over three years beginning on July
3, 2018. Vesting will accelerate if the Company undergoes a change
of control transaction for cash.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Each of Dr. Urbanksi and Dr. Bonfiglio is expected to enter into an
Indemnification Agreement with the Company, the terms of which are
described in Item 1.01 of this Current Report on Form 8-K and the
form of such agreement is filed herein as Exhibit 10.1. There are
no arrangements or understandings between Dr. Bonfiglio and any
person pursuant to which he was appointed as a member of the
Company&#x2019;s Board. There are no transactions in which Dr.
Urbanksi or Dr. Bonfiglio had or will have an interest that would
be required to be disclosed pursuant to Item 404(a) of Regulation
S-K under the Securities Exchange Act of 1934, as
amended.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
ITEM 9.01 Exhibits.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px"><a href="gtbp_ex101.htm"><font style="color: #000000; background-color: #FFFFFF">10.1</font></a>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Form of Indemnification Agreement</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SIGNATURE PAGE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant
to the requirement of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align: top; width: 42%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
GT Biopharma, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
July 3, 2018</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:</font></div>
</td>
<td style="vertical-align: top; width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">/s/
Steven Weldon</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">Steven
Weldon</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Financial Officer</font></div>
</td>
<td style="vertical-align: middle; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>gtbp_ex101.htm
<DESCRIPTION>FORM OF INDEMNIFICATION AGREEMENT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2018 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times\ New\ Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Exhibit 10.1</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
INDEMNIFICATION AGREEMENT</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">This Indemnification Agreement, dated
[__________], is made between GT Biopharma, Inc., a Delaware
corporation (the &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Company</font><font style="color: #000000">&#x201D;),
and [__________]&#xA0;(the &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Indemnitee</font><font style="color: #000000">&#x201D;).</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-family: Times New Roman; font-size: 13px">
RECITALS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">A.
The Company desires to attract and retain the services of talented
and experienced individuals, such as Indemnitee, to serve as
directors and officers of the Company and its subsidiaries and
wishes to indemnify its directors and officers to the maximum
extent permitted by law;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">B.
The Company and Indemnitee recognize that corporate litigation in
general has subjected directors and officers to expensive
litigation risks;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">C. Section&#xA0;145 of the General Corporation Law
of Delaware, under which the Company is organized
(&#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Section&#xA0;145</font><font style="color: #000000">&#x201D;),
empowers the Company to indemnify its directors and officers by
agreement and to indemnify persons who serve, at the request of the
Company, as the directors and officers of other corporations or
enterprises, and expressly provides that the indemnification
provided by Section&#xA0;145 is not exclusive;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">D. Section&#xA0;145(g) allows for the purchase of
management liability (&#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">D&amp;O</font><font style="color: #000000">&#x201D;)
insurance by the Company, which in theory can cover asserted
liabilities without regard to whether they are indemnifiable or
not;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">E.
Individuals considering service or presently serving expect to be
extended market terms of indemnification commensurate with their
position, and that entities such as Company will endeavor to
maintain appropriate D&amp;O insurance; and</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">F.
In order to induce Indemnitee to serve or continue to serve as a
director or officer of the Company and/or one or more subsidiaries
of the Company, the Company and Indemnitee enter into this
Agreement.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-family: Times New Roman; font-size: 13px">
AGREEMENT</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">NOW,
THEREFORE, Indemnitee and the Company hereby agree as
follows:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">1.&#xA0;</font><font style="text-decoration: underline; color: #000000">Definitions</font><font style="color: #000000">.
As used in this Agreement:</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(a) &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Agent</font><font style="color: #000000">&#x201D;
means any person who is or was a director, officer, employee or
other agent of the Company or a subsidiary of the Company; or is or
was serving at the request of, for the convenience of, or to
represent the interests of the Company or a subsidiary of the
Company as a director, officer, employee or agent of another
foreign or domestic corporation, limited liability company,
employee benefit plan, nonprofit entity, partnership, joint
venture, trust or other enterprise; or was a director, officer,
employee or agent of a foreign or domestic corporation which was a
predecessor corporation of the Company or a subsidiary of the
Company, or was a director, officer, employee or agent of another
enterprise at the request of, for the convenience of, or to
represent the interests of such predecessor
corporation.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(b) &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Board</font><font style="color: #000000">&#x201D;
means the Board of Directors of the Company.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(c) A &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Change in
Control</font><font style="color: #000000">&#x201D; shall be deemed
to have occurred if (i)&#xA0;any &#x201C;person,&#x201D; as such term
is used in Sections 13(d) and 14(d) of the Securities Exchange Act
of 1934, as amended (the &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Exchange
Act</font><font style="color: #000000">&#x201D;), other than a
trustee or other fiduciary holding securities under an employee
benefit plan of the Company or a corporation owned directly or
indirectly by the stockholders of the Company in substantially the
same proportions as their ownership of stock of the Company, is or
becomes the &#x201C;beneficial owner&#x201D; (as defined in Rule
13d-3 under the Exchange Act), directly or indirectly, of
securities of the Company representing a majority of the total
voting power represented by the Company&#x2019;s then outstanding
voting securities, (ii)&#xA0;during any period of two consecutive
years, individuals who at the beginning of such period constituted
the Board, together with any new directors whose election by the
Board or nomination for election by the Company&#x2019;s
stockholders was approved by a vote of at least two-thirds of the
directors then still in office who either were directors at the
beginning of the period or whose election or nomination was
previously so approved, cease for any reason to constitute a
majority of the Board, (iii)&#xA0;the stockholders of the Company
approve a merger or consolidation or a sale of all or substantially
all of the Company&#x2019;s assets with or to another entity, other
than a merger, consolidation or asset sale that would result in the
holders of the Company&#x2019;s outstanding voting securities
immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities
of the surviving entity) at least a majority of the total voting
power represented by the voting securities of the Company or such
surviving or successor entity outstanding immediately thereafter,
or (iv)&#xA0;the stockholders of the Company approve a plan of
complete liquidation of the Company.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(d) &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Expenses</font><font style="color: #000000">&#x201D;
shall include all out-of-pocket costs of any type or nature
whatsoever (including, without limitation, all attorneys&#x2019;
fees and related disbursements), actually and reasonably incurred
by Indemnitee in connection with either the investigation, defense
or appeal of a Proceeding or establishing or enforcing a right to
indemnification under this Agreement, or Section&#xA0;145 or
otherwise; provided, however, that &#x201C;Expenses&#x201D; shall not
include any judgments, fines, ERISA excise taxes or penalties, or
amounts paid in settlement of a Proceeding.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">&#xA0;(e) &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Proceeding</font><font style="color: #000000">&#x201D;
means any threatened, pending, or completed action, claim, suit,
arbitration, alternate dispute resolution mechanism, investigation,
administrative hearing or any other proceeding whether formal or
informal, civil, criminal, administrative, or investigative,
including, but not limited to, any such investigation or proceeding
instituted by or on behalf of the Corporation or its Board of
Directors, in which Indemnitee is or reasonably may be involved as
a party or target, that is associated with Indemnitee&#x2019;s being
an Agent of the Corporation.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(f) &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Subsidiary</font><font style="color: #000000">&#x201D;
means any corporation of which more than 50% of the outstanding
voting securities is owned directly or indirectly by the Company,
by the Company and one or more other subsidiaries, or by one or
more other subsidiaries.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">2.&#xA0;</font><font style="text-decoration: underline; color: #000000">Agreement to
Serve</font><font style="color: #000000">. Indemnitee has served,
agrees to serve, and/or continue to serve as an Agent of the
Company, at its will (or under separate agreement, if such
agreement exists), in the capacity Indemnitee currently serves as
an Agent of the Company, so long as Indemnitee is duly appointed or
elected and qualified in accordance with the applicable provisions
of the Bylaws of the Company or any subsidiary of the Company or
until such time as Indemnitee tenders his or her resignation in
writing; provided, however, that nothing contained in this
Agreement is intended to create any right to continued employment
or other service by Indemnitee, or otherwise mandate any specific
length of past or future service to avail Indemnitee of the
provisions of Section 4 below.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">3.&#xA0;</font><font style="text-decoration: underline; color: #000000">Liability
Insurance</font><font style="color: #000000">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(a)&#xA0;</font><font style="text-decoration: underline; color: #000000">Maintenance of D&amp;O
Insurance</font><font style="color: #000000">. The Company hereby
covenants and agrees that, so long as Indemnitee shall continue to
serve as an Agent of the Company and thereafter so long as
Indemnitee shall be subject to any possible Proceeding by reason of
the fact that Indemnitee was an Agent of the Company, the Company,
subject to Section&#xA0;3(c), shall promptly obtain and maintain in
full force and effect directors&#x2019; and officers&#x2019;
liability insurance (&#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">D&amp;O
Insurance</font><font style="color: #000000">&#x201D;) in reasonable
amounts from established and reputable insurers, as more fully
described below. In the event of a Change in Control, the Company
shall, as set forth in Section (c)&#xA0;below, either: (i) maintain
such D&amp;O Insurance for six years; or (ii) purchase a six-year
tail for such D&amp;O Insurance.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(b)&#xA0;</font><font style="text-decoration: underline; color: #000000">Rights and
Benefits</font><font style="color: #000000">. In all policies of
D&amp;O Insurance, Indemnitee shall qualify as an insured in such a
manner as to provide Indemnitee the same rights and benefits as are
accorded to the most favorably insured of the Company&#x2019;s
independent directors (as defined by the insurer) if Indemnitee is
such an independent director; of the Company&#x2019;s
non-independent directors if Indemnitee is not an independent
director; of the Company&#x2019;s officers if Indemnitee is an
officer of the Company; or of the Company&#x2019;s key employees, if
Indemnitee is not a director or officer but is a key
employee.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(c)&#xA0;</font><font style="text-decoration: underline; color: #000000">Limitation on Required
Maintenance of D&amp;O Insurance</font><font style="color: #000000">. Notwithstanding the foregoing, the Company shall
have no obligation to obtain or maintain D&amp;O Insurance at all,
or of any type, terms, or amount, if the Company determines in good
faith that: such insurance is not reasonably available; the premium
costs for such insurance are disproportionate to the amount of
coverage provided; the coverage provided by such insurance is
limited so as to provide an insufficient or unreasonable benefit;
Indemnitee is covered by similar insurance maintained by a
subsidiary of the Company; or the Company is to be acquired and a
tail policy of reasonable terms and duration can be purchased for
pre-closing acts or omissions by Indemnitee.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">4.&#xA0;</font><font style="text-decoration: underline; color: #000000">Mandatory
Indemnification</font><font style="color: #000000">. Subject to the
terms of this Agreement:</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(a)&#xA0;</font><font style="text-decoration: underline; color: #000000">Third Party
Actions</font><font style="color: #000000">. If Indemnitee is a
person who was or is a party or is threatened to be made a party to
any Proceeding (other than an action by or in the right of the
Company) by reason of the fact that Indemnitee is or was an Agent
of the Company, or by reason of anything done or not done by
Indemnitee in any such capacity, the Company shall indemnify
Indemnitee against all Expenses and liabilities of any type
whatsoever (including, but not limited to, judgments, fines, ERISA
excise taxes and penalties, and amounts paid in settlement)
actually and reasonably incurred by Indemnitee in connection with
the investigation, defense, settlement or appeal of such
Proceeding.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(b)&#xA0;</font><font style="text-decoration: underline; color: #000000">Derivative
Actions</font><font style="color: #000000">. If Indemnitee is a
person who was or is a party or is threatened to be made a party to
any Proceeding by or in the right of the Company by reason of the
fact that Indemnitee is or was an Agent of the Company, or by
reason of anything done or not done by Indemnitee in any such
capacity, the Company shall indemnify Indemnitee against all
Expenses actually and reasonably incurred by Indemnitee in
connection with the investigation, defense, settlement or appeal of
such Proceeding, provided Indemnitee acted in good faith and in a
manner Indemnitee reasonably believed to be in or not opposed to
the best interests of the Company.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(c)&#xA0;</font><font style="text-decoration: underline; color: #000000">Actions where
Indemnitee is Deceased</font><font style="color: #000000">. If
Indemnitee is a person who was or is a party or is threatened to be
made a party to any Proceeding by reason of the fact that
Indemnitee is or was an Agent of the Company, or by reason of
anything done or not done by Indemnitee in any such capacity, and
if, prior to, during the pendency of or after completion of such
Proceeding Indemnitee is deceased, the Company shall indemnify
Indemnitee&#x2019;s heirs, executors and administrators against all
Expenses and liabilities of any type whatsoever to the extent
Indemnitee would have been entitled to indemnification pursuant to
this Agreement were Indemnitee still alive.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(d)&#xA0;</font><font style="text-decoration: underline; color: #000000">Limitations</font><font style="color: #000000">.
Notwithstanding the foregoing provisions of Sections 4(a), 4(b),
and 4(c) hereof, but subject to the exception set forth in
Section&#xA0;13 which shall control, the Company shall not be
obligated to indemnify the Indemnitee for Expenses or liabilities
of any type whatsoever for which payment (and the Company&#x2019;s
indemnification obligations under this Agreement shall be reduced
by such payment) is actually made to or on behalf of Indemnitee, by
the Company or otherwise, under a corporate insurance policy, or
under a valid and enforceable indemnity clause, right, by-law, or
agreement; and, in the event the Company has previously made a
payment to Indemnitee for an Expense or liability of any type
whatsoever for which payment is actually made to or on behalf of
the Indemnitee under an insurance policy, or under a valid and
enforceable indemnity clause, by-law or agreement, Indemnitee shall
return to the Company the amounts subsequently received by the
Indemnitee from such other source of
indemnification.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(e)</font> <font style="text-decoration: underline; color: #000000">D&amp;O Insurance
Carveout</font><font style="color: #000000">. Capitalized terms in
this subsection not defined in this Agreement are defined in the
Company&#x2019;s current D&amp;O Insurance policy. In relevant part,
the D&amp;O Insurance presently maintained by the Company states
that t</font>he Insurer shall pay Loss of any Insured Person
arising from a Claim first made during the Policy Period against
such Insured Person for a Wrongful Act, <font style="font-style: italic">if the Company has not indemnified the Insured
Person for such Loss</font>. It is the intention of the parties
hereto that the indemnification provided by this Agreement does not
apply to any Loss covered by the Insurer in any D&amp;O Insurance
policy, provided that the indemnification under this Agreement
shall apply to any such Loss that the Insurer fails to pay for any
reason, including expiration of the D&amp;O Insurance policy,
failure to provide notice(s) required by the D&amp;O Insurance
Policy, or disputes concerning coverage under the D&amp;O Insurance
Policy.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(f)&#xA0;</font><font style="text-decoration: underline; color: #000000">Witness.</font><font style="color: #000000">&#xA0;In
the event that Indemnitee is not a party or threatened to be made a
party to a Proceeding, but is subpoenaed (or given a written
request to be interviewed by a government authority) in such a
Proceeding by reason of the fact that the Indemnitee is or was an
Agent of the Company, or by reason of anything witnessed or
allegedly witnessed by the Indemnitee in that capacity, the Company
shall indemnify the Indemnitee against all actually and reasonably
incurred out of pocket costs of any type or nature whatsoever
(including, without limitation, all attorneys&#x2019; fees and
related disbursements), actually and reasonably incurred by
Indemnitee in responding to such subpoena or written request for an
interview. As a condition to this right, Indemnitee must provide
notice of such subpoena or request to the Company within 14 days of
Indemnitee&#x2019;s actual receipt thereof (this notice condition
shall control over Section&#xA0;6(a), which shall not apply to this
Section 4(g)).</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">5.&#xA0;</font><font style="text-decoration: underline; color: #000000">Mandatory Advancement
of Expenses</font><font style="color: #000000">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(a)
Subject to the terms of this Agreement and following notice
pursuant to Section&#xA0;6(a) below, the Company shall advance all
Expenses reasonably incurred by Indemnitee in connection with the
investigation, defense, settlement or appeal of any Proceeding to
which Indemnitee is a party or is threatened to be made a party by
reason of the fact that Indemnitee is or was an Agent of the
Company upon receipt satisfactory documentation supporting such
Expenses. By execution of this Agreement, Indemnitee agrees to
repay the amount advanced only in the event and to the extent that
it shall ultimately be determined that Indemnitee is not entitled
to indemnification by the Company to the extent set forth in this
agreement or under Delaware law. Such advances are intended to be
an obligation of the Company to Indemnitee hereunder and shall in
no event be deemed to be a personal loan. Such advancement of
Expenses shall otherwise be unsecured and without regard to
Indemnitee&#x2019;s ability to repay. The advances to be made
hereunder shall be paid by the Company to Indemnitee within 30 days
following delivery of a written request therefore by Indemnitee to
the Company, along with such documentation and information as is
reasonably available to the claimant and is reasonably necessary to
determine whether and to what extent the claimant is entitled to
advancement (which shall include without limitation detailed
invoices for legal services). The Company shall discharge its
advancement duty by, at its option, (a)&#xA0;paying such Expenses
on behalf of Indemnitee, (b)&#xA0;advancing to Indemnitee funds in
an amount sufficient to pay such Expenses, or (c)&#xA0;reimbursing
Indemnitee for Expenses already paid by Indemnitee. In the event
that the Company fails to pay Expenses as incurred by Indemnitee as
required by this paragraph, Indemnitee may seek mandatory
injunctive relief (including without limitation specific
performance) from any court having jurisdiction to require the
Company to pay Expenses as set forth in this paragraph. If
Indemnitee seeks mandatory injunctive relief pursuant to this
paragraph, it shall not be a defense to enforcement of the
Company&#x2019;s obligations set forth in this paragraph that
Indemnitee has an adequate remedy at law for damages.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(b)&#xA0;</font><font style="text-decoration: underline; color: #000000">Undertakings.</font><font style="color: #000000">&#xA0;Indemnitee
shall qualify for advances upon the execution and delivery to the
Company of this Agreement, which constitutes an undertaking whereby
Indemnitee promises to repay any amounts advances in the event
there shall be a final determination that Indemnitee is not
entitled to indemnification by the Company.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">6.&#xA0;</font><font style="text-decoration: underline; color: #000000">Notice and Other
Indemnification Procedures</font><font style="color: #000000">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(a)&#xA0;</font><font style="text-decoration: underline; color: #000000">Notice by
Indemnitee</font><font style="color: #000000">. Promptly after
receipt by Indemnitee of notice of the commencement of or the
threat of commencement of any Proceeding, Indemnitee shall, if
Indemnitee believes that indemnification with respect thereto may
be sought from the Company under this Agreement, notify the Company
in writing of the commencement or threat of commencement thereof.
Notwithstanding the foregoing, any failure of Indemnitee to provide
such a notice to the Company, or to provide such a notice in a
timely fashion, shall not relieve the Company of any liability that
it may have to Indemnitee unless, and to the extent that, such
failure actually and materially prejudices the interests of the
Company.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(b)&#xA0;</font><font style="text-decoration: underline; color: #000000">Insurance</font><font style="color: #000000">.
If the Company receives notice pursuant to Section&#xA0;6(a) hereof
of the commencement of a Proceeding that may be covered under
D&amp;O Insurance then in effect, the Company shall give prompt
notice of the commencement of such Proceeding to the insurers in
accordance with the procedures set forth in the respective
policies.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(c)&#xA0;</font><font style="text-decoration: underline; color: #000000">Defense</font><font style="color: #000000">.
In the event the Company shall be obligated to pay the Expenses of
any Proceeding against Indemnitee, the Company shall be entitled to
assume the defense of such Proceeding, with counsel selected by the
Company and approved by Indemnitee (which approval shall not be
unreasonably withheld), upon the delivery to Indemnitee of written
notice of the Company&#x2019;s election so to do. After delivery of
such notice, and the retention of such counsel by the Company, the
Company will not be liable to Indemnitee under this Agreement for
any fees of counsel subsequently incurred by Indemnitee with
respect to the same Proceeding, provided that (i)&#xA0;Indemnitee
shall have the right to employ his or her own counsel in any such
Proceeding at Indemnitee&#x2019;s expense; and (ii)&#xA0;Indemnitee
shall have the right to employ his or her own counsel in any such
Proceeding at the Company&#x2019;s expense if (A)&#xA0;the Company
has authorized&#xA0;the employment of counsel by Indemnitee at the
expense of the Company; (B)&#xA0;Indemnitee shall have reasonably
concluded based on the written advice of Indemnitee&#x2019;s legal
counsel that there may be a conflict of interest between the
Company and Indemnitee in the conduct of any such defense; or
(C)&#xA0;the Company shall not, in fact, have employed counsel to
assume the defense of such Proceeding. In addition to all the
requirements above,&#xA0;if the Company has D&amp;O Insurance, or
other insurance, with a panel counsel requirement that may cover
the matter for which indemnity is claimed by Indemnitee, then
Indemnitee shall use such panel counsel or other counsel approved
by the insurers, unless there is an actual conflict of interest
posed by representation by all such counsel, or unless and to the
extent&#xA0;Company waives such requirement in writing. Indemnitee
and its counsel shall provide reasonable cooperation with such
insurer on request of the Company.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(d)&#xA0;</font><font style="text-decoration: underline; color: #000000">Notice to
Indemnitee</font><font style="color: #000000">. Promptly after
receipt by the Company of notice of the commencement of or the
threat of commencement of any Proceeding, the Company shall, if the
Company believes that Indemnitee may be a party to or otherwise
affected by such Proceeding, notify Indemnitee in writing of the
commencement or threat of commencement thereof.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">7.&#xA0;</font><font style="text-decoration: underline; color: #000000">Exceptions</font><font style="color: #000000">.
Any other provision herein to the contrary notwithstanding, the
Company shall not be obligated:</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(a)&#xA0;</font><font style="text-decoration: underline; color: #000000">Claims Initiated by
Indemnitee</font><font style="color: #000000">. To indemnify or
advance Expenses to Indemnitee with respect to Proceedings or
claims initiated or brought voluntarily by Indemnitee and not by
way of defense, with a reasonable allocation where appropriate,
unless (i)&#xA0;such indemnification is expressly required to be
made by law, (ii)&#xA0;the Proceeding was authorized by the Board,
(iii)&#xA0;such indemnification is provided by the Company, in its
sole discretion, pursuant to the powers vested in the Company under
the General Corporation Law of Delaware or (iv)&#xA0;the Proceeding
is brought specifically to establish or enforce a right to
indemnification under this Agreement or any other statute or law or
otherwise;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(b)&#xA0;</font><font style="text-decoration: underline; color: #000000">Fees on
Fees</font><font style="color: #000000">. To indemnify Indemnitee
for any Expenses incurred by Indemnitee with respect to any
Proceeding instituted by Indemnitee to enforce or interpret this
Agreement, to the extent Indemnitee is not successful in such a
Proceeding;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(c)&#xA0;</font><font style="text-decoration: underline; color: #000000">Unauthorized
Settlements</font><font style="color: #000000">. To indemnify
Indemnitee under this Agreement for any amounts paid in settlement
of a Proceeding unless the Company consents to such settlement,
which consent shall not be unreasonably
withheld;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(d)&#xA0;</font><font style="text-decoration: underline; color: #000000">Claims Under
Section&#xA0;16(b)</font><font style="color: #000000">. To
indemnify Indemnitee for Expenses associated with any Proceeding
related to, or the payment of profits made from the purchase and
sale (or sale and purchase) by Indemnitee of securities of the
Company within the meaning of Section&#xA0;16(b) of the Securities
Exchange Act of 1934, as amended, or similar provisions of state
statutory law or common law (provided, however, that the Company
must advance Expenses for such matters as otherwise permissible
under this Agreement); or</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(e)&#xA0;</font><font style="text-decoration: underline; color: #000000">Payments Contrary to
Law</font><font style="color: #000000">. To indemnify or advance
Expenses to Indemnitee for which payment is prohibited by
applicable law.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">8.&#xA0;</font><font style="text-decoration: underline; color: #000000">Non-Exclusivity</font><font style="color: #000000">.
The provisions for indemnification and advancement of Expenses set
forth in this Agreement shall not be deemed exclusive of any other
rights which Indemnitee may have under any provision of law, the
Company&#x2019;s Certificate of Incorporation or Bylaws, the vote of
the Company&#x2019;s stockholders or disinterested directors, other
agreements, or otherwise, both as to action in Indemnitee&#x2019;s
official capacity and as to action in another capacity while
occupying Indemnitee&#x2019;s position as an Agent of the Company.
However, this Agreement replaces any prior contractual
indemnification agreement between Indemnitee and Company (including
when operating under a different name). Indemnitee&#x2019;s rights
hereunder shall continue after Indemnitee has ceased acting as an
Agent of the Company and shall inure to the benefit of the heirs,
executors and administrators of Indemnitee.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">9.&#xA0;</font><font style="text-decoration: underline; color: #000000">Permitted
Defenses</font><font style="color: #000000">. It shall be a defense
to any action for which a claim for indemnification is made under
this Agreement (other than an action brought to enforce a claim for
Expenses pursuant to Section&#xA0;5 hereof, provided that the
required documents have been tendered to the Company) that
Indemnitee is not entitled to indemnification because of the
limitations set forth in Sections&#xA0;4 and 8
hereof.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">10.&#xA0;</font><font style="text-decoration: underline; color: #000000">Subrogation</font><font style="color: #000000">.
In the event the Company is obligated to make a payment under this
Agreement, the Company shall be subrogated to the extent of such
payment to all of the rights of recovery under any corporate
insurance policy or any other indemnity agreement covering
Indemnitee, who shall execute all documents reasonably required and
take all action that may be necessary to secure such rights and to
enable the Company effectively to bring suit to enforce such rights
(provided that the Company pays Indemnitee&#x2019;s costs and
expenses of doing so), including without limitation by assigning
all such rights to the Company or its designee to the extent of
such indemnification or advancement of Expenses. The
Company&#x2019;s obligation to indemnify or advance expenses under
this Agreement shall be reduced by any amount Indemnitee has
collected from such other source, and in the event that Company has
fully paid such indemnity or expenses, Indemnitee shall return to
the Company any amounts subsequently received from such other
source of indemnification. With regard to Fund Indemnitors,
however, Section&#xA0;12 shall control over this
section.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">11.&#xA0;</font><font style="text-decoration: underline; color: #000000">Primacy of
Indemnification</font><font style="color: #000000">. The Company
hereby acknowledges that Indemnitee may have certain rights to
indemnification, advancement of expenses or liability insurance
provided by a third-party investor and certain of its affiliates
(collectively, the &#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Fund
Indemnitors</font><font style="color: #000000">&#x201D;). The
Company hereby agrees that (i)&#xA0;it is the indemnitor of first
resort,&#xA0;</font><font style="font-style: italic; color: #000000">i.e.</font><font style="color: #000000">, its obligations to Indemnitee under this
Agreement and any indemnity provisions set forth in its Certificate
of Incorporation, Bylaws or elsewhere (collectively,
&#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000">Indemnity
Arrangements</font><font style="color: #000000">&#x201D;) are
primary, and any obligation of the Fund Indemnitors to advance
expenses or to provide indemnification for the same expenses or
liabilities incurred by Indemnitee is secondary and excess,
(ii)&#xA0;it shall advance the full amount of expenses incurred by
Indemnitee and shall be liable for the full amount of all expenses,
judgments, penalties, fines and amounts paid in settlement by or on
behalf of Indemnitee, to the extent legally permitted and as
required by any Indemnity Arrangement, without regard to any rights
Indemnitee may have against the Fund Indemnitors, and (iii)&#xA0;it
irrevocably waives, relinquishes and releases the Fund Indemnitors
from any claims against the Fund Indemnitors for contribution,
subrogation or any other recovery relating to any Indemnity
Arrangement. The Company further agrees that no advancement or
indemnification payment by any Fund Indemnitor on behalf of
Indemnitee shall affect the foregoing, and the Fund Indemnitors
shall be subrogated to the extent of such advancement or payment to
all of the rights of recovery of Indemnitee against the Company.
The Company and Indemnitee agree that the Fund Indemnitors are
express third party beneficiaries of the terms of this
Section&#xA0;11. The Company, on its own behalf and on behalf of
its insurers to the extent allowed by the policies, waives
subrogation rights against Indemnitee.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">12.&#xA0;</font><font style="text-decoration: underline; color: #000000">Survival of
Rights</font><font style="color: #000000">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(a)
All agreements and obligations of the Company contained herein
shall continue during the period Indemnitee is an Agent of the
Company and shall continue thereafter so long as Indemnitee shall
be subject to any possible claim or threatened, pending or
completed Proceeding by reason of the fact that Indemnitee was
serving in the capacity referred to herein.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 72px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(b)
The Company shall require any successor to the Company (whether
direct or indirect, by purchase, merger, consolidation or
otherwise) to all or substantially all of the business or assets of
the Company, expressly to assume and agree to perform this
Agreement in the same manner and to the same extent that the
Company would be required to perform if no such succession had
taken place.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">13.&#xA0;</font><font style="text-decoration: underline; color: #000000">Interpretation of
Agreement</font><font style="color: #000000">. It is understood
that the parties hereto intend this Agreement to be interpreted and
enforced so as to provide indemnification to Indemnitee to the
fullest extent permitted by law, including those circumstances in
which indemnification would otherwise be
discretionary.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">14.&#xA0;</font><font style="text-decoration: underline; color: #000000">Severability</font><font style="color: #000000">.
If any provision or provisions of this Agreement shall be held to
be invalid, illegal or unenforceable for any reason whatsoever,
(i)&#xA0;the validity, legality and enforceability of the remaining
provisions of the Agreement (including, without limitation, all
portions of any paragraphs of this Agreement containing any such
provision held to be invalid, illegal or unenforceable, that are
not themselves invalid, illegal or unenforceable) shall not in any
way be affected or impaired thereby, and (ii)&#xA0;to the fullest
extent possible, the provisions of this Agreement (including,
without limitation, all portions of any paragraph of this Agreement
containing any such provision held to be invalid, illegal or
unenforceable, that are not themselves invalid, illegal or
unenforceable) shall be construed so as to give effect to the
intent manifested by the provision held invalid, illegal or
unenforceable.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">15.&#xA0;</font><font style="text-decoration: underline; color: #000000">Modification and
Waiver</font><font style="color: #000000">. No supplement,
modification or amendment of this Agreement shall be binding unless
it is in a writing signed by both of the parties hereto. No waiver
of any of the provisions of this Agreement shall be deemed or shall
constitute a waiver of any other provisions hereof (whether or not
similar) nor shall such waiver constitute a continuing waiver. In
the event of any change after the date of this Agreement in any
applicable law that expands the right of a Delaware corporation to
indemnify a member of an Agent in the same capacity as Indemnitee,
it is the intent of the parties hereto that Indemnitee shall enjoy
by this Agreement the greater benefits afforded by such change. Any
narrowing change in any applicable law, however, shall have no
effect on the rights and obligations under this Agreement other
than as may be required by law.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">16.&#xA0;</font><font style="text-decoration: underline; color: #000000">Notice</font><font style="color: #000000">.
All notices, requests, demands and other communications under this
Agreement shall be in writing and shall be deemed to have been duly
given (a)&#xA0;upon delivery if delivered by hand to the party to
whom such notice or other communication shall have been directed,
(b)&#xA0;if mailed by certified or registered mail with postage
prepaid, return receipt requested, on the third business day after
the date on which it is so mailed, (c)&#xA0;one business day after
the business day of deposit with a nationally recognized overnight
delivery service, specifying next day delivery, with written
verification of receipt, or (d)&#xA0;on the same day as delivered
by confirmed facsimile transmission if delivered during business
hours or on the next successive business day if delivered by
confirmed facsimile transmission after business hours. Addresses
for notice to either party shall be as shown on the signature page
of this Agreement, or to such other address as may have been
furnished by either party in the manner set forth
above.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">17.&#xA0;</font><font style="text-decoration: underline; color: #000000">Governing
Law</font><font style="color: #000000">. This Agreement shall be
governed exclusively by and construed according to the laws of the
State of Delaware as applied to contracts between Delaware
residents entered into and to be performed entirely within
Delaware. This Agreement is intended to be an agreement of the type
contemplated by Section&#xA0;145(f) of the General Corporation Law
of Delaware.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">18.&#xA0;</font><font style="text-decoration: underline; color: #000000">Counterparts</font><font style="color: #000000">.
This Agreement may be executed in one or more counterparts, each of
which shall for all purposes be deemed to be an original but all of
which together shall constitute one and the same Agreement. Only
one such counterpart signed by the party against whom enforcement
is sought needs to be produced to evidence the existence of this
Agreement.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
[Signature page follows.]</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
parties hereto have entered into this Indemnification Agreement,
including the undertaking contained herein, effective as of the
date first above written.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 49%">
<div style="text-align: justify; margin-left: 24px; margin-right: 12px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Indemnitee:</font></div>
<div style="text-align: justify; margin-left: 24px; margin-right: 12px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 24px; margin-right: 12px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">_________________________________________<br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 84px; margin-right: 12px; text-indent: -60px">
<font style="font-family: Times New Roman; font-size: 13px">Address:
_________________________________________</font></div>
<div style="text-align: justify; margin-left: 84px; margin-right: 12px; text-indent: -60px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0; &#xA0;
&#xA0; &#xA0; &#xA0; &#xA0; &#xA0; &#xA0;&#xA0; <font style="font-family: Times\ New\ Roman; font-size: 13px;">_________________________________________</font>
&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 51%">
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">GT
Biopharma, Inc.:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:&#xA0;&#xA0;<font style="text-decoration: underline">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Name:&#xA0;<font style="text-decoration: underline">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;<br>
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Title:&#xA0;<font style="text-decoration: underline">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;<br>
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
